Hardware, Equipment & Parts
Compare Stocks
3 / 10Stock Comparison
BMI vs ITRI vs FELE
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Industrial - Machinery
BMI vs ITRI vs FELE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Industrial - Machinery |
| Market Cap | $3.65B | $3.68B | $4.46B |
| Revenue (TTM) | $917M | $2.35B | $2.18B |
| Net Income (TTM) | $142M | $289M | $150M |
| Gross Margin | 41.7% | 38.6% | 35.2% |
| Operating Margin | 20.0% | 13.2% | 12.6% |
| Forward P/E | 27.3x | 13.8x | 22.0x |
| Total Debt | $0.00 | $1.29B | $280M |
| Cash & Equiv. | $226M | $1.02B | $100M |
BMI vs ITRI vs FELE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Badger Meter, Inc. (BMI) | 100 | 200.4 | +100.4% |
| Itron, Inc. (ITRI) | 100 | 130.1 | +30.1% |
| Franklin Electric C… (FELE) | 100 | 197.5 | +97.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMI vs ITRI vs FELE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BMI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 33 yrs, beta 0.87, yield 1.2%
- Rev growth 10.9%, EPS growth 13.2%, 3Y rev CAGR 17.5%
- 253.2% 10Y total return vs FELE's 233.1%
ITRI is the clearest fit if your priority is value.
- Lower P/E (13.8x vs 22.0x)
FELE is the clearest fit if your priority is momentum.
- +17.9% vs BMI's -44.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.9% revenue growth vs ITRI's -3.0% | |
| Value | Lower P/E (13.8x vs 22.0x) | |
| Quality / Margins | 15.5% margin vs FELE's 6.9% | |
| Stability / Safety | Beta 0.87 vs ITRI's 1.53 | |
| Dividends | 1.2% yield, 33-year raise streak, vs FELE's 1.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +17.9% vs BMI's -44.1% | |
| Efficiency (ROA) | 14.5% ROA vs FELE's 7.6%, ROIC 34.5% vs 14.7% |
BMI vs ITRI vs FELE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BMI vs ITRI vs FELE — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BMI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ITRI is the larger business by revenue, generating $2.3B annually — 2.6x BMI's $917M. BMI is the more profitable business, keeping 15.5% of every revenue dollar as net income compared to FELE's 6.9%. On growth, FELE holds the edge at +9.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $917M | $2.3B | $2.2B |
| EBITDAEarnings before interest/tax | $218M | $367M | $322M |
| Net IncomeAfter-tax profit | $142M | $289M | $150M |
| Free Cash FlowCash after capex | $170M | $393M | $169M |
| Gross MarginGross profit ÷ Revenue | +41.7% | +38.6% | +35.2% |
| Operating MarginEBIT ÷ Revenue | +20.0% | +13.2% | +12.6% |
| Net MarginNet income ÷ Revenue | +15.5% | +12.3% | +6.9% |
| FCF MarginFCF ÷ Revenue | +18.5% | +16.7% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.6% | -3.3% | +9.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.6% | -16.9% | +13.4% |
Valuation Metrics
ITRI leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, ITRI trades at a 59% valuation discount to FELE's 31.1x P/E. Adjusting for growth (PEG ratio), BMI offers better value at 1.12x vs FELE's 3.56x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $3.6B | $3.7B | $4.5B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $3.9B | $4.6B |
| Trailing P/EPrice ÷ TTM EPS | 25.84x | 12.74x | 31.07x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.28x | 13.77x | 22.00x |
| PEG RatioP/E ÷ EPS growth rate | 1.12x | — | 3.56x |
| EV / EBITDAEnterprise value multiple | 15.69x | 10.70x | 13.95x |
| Price / SalesMarket cap ÷ Revenue | 3.98x | 1.55x | 2.09x |
| Price / BookPrice ÷ Book value/share | 5.13x | 2.20x | 3.44x |
| Price / FCFMarket cap ÷ FCF | 21.49x | 9.66x | 23.04x |
Profitability & Efficiency
BMI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BMI delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $11 for FELE. FELE carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITRI's 0.74x. On the Piotroski fundamental quality scale (0–9), ITRI scores 7/9 vs BMI's 4/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +19.9% | +17.2% | +11.4% |
| ROA (TTM)Return on assets | +14.5% | +7.7% | +7.6% |
| ROICReturn on invested capital | +34.5% | +13.1% | +14.7% |
| ROCEReturn on capital employed | +24.1% | +11.4% | +18.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 5 |
| Debt / EquityFinancial leverage | — | 0.74x | 0.21x |
| Net DebtTotal debt minus cash | -$226M | $267M | $181M |
| Cash & Equiv.Liquid assets | $226M | $1.0B | $100M |
| Total DebtShort + long-term debt | $0 | $1.3B | $280M |
| Interest CoverageEBIT ÷ Interest expense | — | 14.38x | 24.75x |
Total Returns (Dividends Reinvested)
Evenly matched — BMI and ITRI and FELE each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMI five years ago would be worth $14,089 today (with dividends reinvested), compared to $9,805 for ITRI. Over the past 12 months, FELE leads with a +17.9% total return vs BMI's -44.1%. The 3-year compound annual growth rate (CAGR) favors ITRI at 7.3% vs BMI's -2.5% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -29.6% | -12.2% | +4.4% |
| 1-Year ReturnPast 12 months | -44.1% | -22.2% | +17.9% |
| 3-Year ReturnCumulative with dividends | -7.4% | +23.5% | +10.8% |
| 5-Year ReturnCumulative with dividends | +40.9% | -2.0% | +21.2% |
| 10-Year ReturnCumulative with dividends | +253.2% | +97.1% | +233.1% |
| CAGR (3Y)Annualised 3-year return | -2.5% | +7.3% | +3.5% |
Risk & Volatility
Evenly matched — BMI and FELE each lead in 1 of 2 comparable metrics.
Risk & Volatility
BMI is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than ITRI's 1.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FELE currently trades 90.5% from its 52-week high vs BMI's 48.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | 1.53x | 0.92x |
| 52-Week HighHighest price in past year | $256.08 | $142.00 | $111.53 |
| 52-Week LowLowest price in past year | $112.09 | $78.53 | $83.42 |
| % of 52W HighCurrent price vs 52-week peak | +48.3% | +58.4% | +90.5% |
| RSI (14)Momentum oscillator 0–100 | 36.2 | 37.6 | 52.1 |
| Avg Volume (50D)Average daily shares traded | 558K | 905K | 284K |
Analyst Outlook
BMI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BMI as "Hold", ITRI as "Hold", FELE as "Hold". Consensus price targets imply 65.1% upside for ITRI (target: $137) vs -1.0% for FELE (target: $100). For income investors, BMI offers the higher dividend yield at 1.19% vs FELE's 1.09%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $172.14 | $137.00 | $100.00 |
| # AnalystsCovering analysts | 18 | 37 | 11 |
| Dividend YieldAnnual dividend ÷ price | +1.2% | — | +1.1% |
| Dividend StreakConsecutive years of raises | 33 | 1 | 32 |
| Dividend / ShareAnnual DPS | $1.47 | — | $1.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +2.7% | +3.7% |
BMI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ITRI leads in 1 (Valuation Metrics). 2 tied.
BMI vs ITRI vs FELE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BMI or ITRI or FELE a better buy right now?
For growth investors, Badger Meter, Inc.
(BMI) is the stronger pick with 10. 9% revenue growth year-over-year, versus -3. 0% for Itron, Inc. (ITRI). Itron, Inc. (ITRI) offers the better valuation at 12. 7x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate Badger Meter, Inc. (BMI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BMI or ITRI or FELE?
On trailing P/E, Itron, Inc.
(ITRI) is the cheapest at 12. 7x versus Franklin Electric Co. , Inc. at 31. 1x. On forward P/E, Itron, Inc. is actually cheaper at 13. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Badger Meter, Inc. wins at 1. 18x versus Franklin Electric Co. , Inc. 's 2. 52x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BMI or ITRI or FELE?
Over the past 5 years, Badger Meter, Inc.
(BMI) delivered a total return of +40. 9%, compared to -2. 0% for Itron, Inc. (ITRI). Over 10 years, the gap is even starker: BMI returned +253. 6% versus ITRI's +97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BMI or ITRI or FELE?
By beta (market sensitivity over 5 years), Badger Meter, Inc.
(BMI) is the lower-risk stock at 0. 87β versus Itron, Inc. 's 1. 53β — meaning ITRI is approximately 76% more volatile than BMI relative to the S&P 500. On balance sheet safety, Franklin Electric Co. , Inc. (FELE) carries a lower debt/equity ratio of 21% versus 74% for Itron, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BMI or ITRI or FELE?
By revenue growth (latest reported year), Badger Meter, Inc.
(BMI) is pulling ahead at 10. 9% versus -3. 0% for Itron, Inc. (ITRI). On earnings-per-share growth, the picture is similar: Itron, Inc. grew EPS 25. 7% year-over-year, compared to -15. 8% for Franklin Electric Co. , Inc.. Over a 3-year CAGR, BMI leads at 17. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BMI or ITRI or FELE?
Badger Meter, Inc.
(BMI) is the more profitable company, earning 15. 5% net margin versus 6. 9% for Franklin Electric Co. , Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BMI leads at 20. 0% versus 12. 7% for FELE. At the gross margin level — before operating expenses — BMI leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BMI or ITRI or FELE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Badger Meter, Inc. (BMI) is the more undervalued stock at a PEG of 1. 18x versus Franklin Electric Co. , Inc. 's 2. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Itron, Inc. (ITRI) trades at 13. 8x forward P/E versus 27. 3x for Badger Meter, Inc. — 13. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 65. 1% to $137. 00.
08Which pays a better dividend — BMI or ITRI or FELE?
In this comparison, BMI (1.
2% yield), FELE (1. 1% yield) pay a dividend. ITRI does not pay a meaningful dividend and should not be held primarily for income.
09Is BMI or ITRI or FELE better for a retirement portfolio?
For long-horizon retirement investors, Badger Meter, Inc.
(BMI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 2% yield, +253. 6% 10Y return). Itron, Inc. (ITRI) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BMI: +253. 6%, ITRI: +97. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BMI and ITRI and FELE?
These companies operate in different sectors (BMI (Technology) and ITRI (Technology) and FELE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BMI is a small-cap quality compounder stock; ITRI is a small-cap deep-value stock; FELE is a small-cap quality compounder stock. BMI, FELE pay a dividend while ITRI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.